We found for
Limitations of CBO’s Simulation Model of New Drug Development as a Tool for Policymakers

Making Outcome-Based Payment a Reality in the NHS. Phase Two: Practical Considerations

It Takes Two to Tango: When do Conditional Reimbursement Risk-Sharing Schemes Work for Both Parties?
